Thousands of young women are unnecessarily admitted to UK hospitals and undergo surgery they do not need each year in the NHS, a new study reveals.
Professor Colin Watts, Chair of the Birmingham Brain Cancer Program, highlights the importance of brain tumour research.
Scientists at the University of Birmingham have found an anti-malarial drug was effective in treating head and neck cancer in mice.
Monica Nafria, PhD student in the Institute of Cancer and Genomic Sciences, has been awarded 1st prize for best oral presentation at the International Society for Experimental Haematology annual meeting.
University of Birmingham scientists may have found a way to pull down the protective wall that surrounds tumours, potentially re-exposing them to the killing power of the immune system and immunotherapy treatments.
An international team from the University of Birmingham and the University of Nottingham in the UK and the Kenya Medical Research Institute in Nairobi, Kenya, has been awarded £660,000 to study prostate cancer.
Three researchers from the University of Birmingham have been awarded more than £4 million by Cancer Research UK for their work to investigate new personalised cancer treatments.
Researchers at the University of Birmingham have shown that it's possible to produce a compound with anti-cancer properties directly from feverfew – a common flowering garden plant.
The Institute of Cancer and Genomic Sciences recently appointed Dr Marc Haber as Junior Group Leader. He joins Birmingham from the Wellcome Sanger Institute bringing with him extensive experience in population genetics.
Second Birmingham Symposium on Genome Structure and Function - 4th to 5th July 2019, Birmingham Centre for Genome Biology